This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
tim.hodson Fri, 03/14/2025 - 16:12 SCAI Scientific Sessions 2025 will take place May 1 to 3, attheWalter E. Washington Convention Center in Washington, DC.
Publication date: Available online 8 April 2025 Source: The American Journal of Cardiology Author(s): Subhash Banerjee, David Fernandez Vazquez, Yu-Lun Liu, Sameh Sayfo, Minseob Jeong, Zachary P. Rosol, Anand Gupta, Blake M. Bruneman, Sarah G. Weideman, Kennedy S. Adelman, Shirling Tsai, Shuaib Abdullah, Hung B. Chu, Bertram L.
Publication date: Available online 1 April 2025 Source: The American Journal of Cardiology Author(s): Michael Gao, Angelo Oliva, Raman Sharma, Frank Kalaba, Samantha Sartori, Serdar Farhan, Kenneth Smith, Birgit Vogel, Prakash Krishnan, George Dangas, Roxana Mehran, Annapoorna Kini, Samin Sharma
Publication date: Available online 26 February 2025 Source: The American Journal of Cardiology Author(s): Mary O. Whipple, Shujun Xu, Dongxue Zhang, Jack Guralnik, Bonnie Spring, Lu Tian, Diane Treat-Jacobson, Lihui Zhao, Michael H. Criqui, Mary M. McDermott
Stroke, Volume 56, Issue Suppl_1 , Page ATP283-ATP283, February 1, 2025. and more likely to have coronary arterydisease, peripheralarterydisease, and chronic liver disease (p < 0.05), however they had similar CHADVASC scores (3.09 Within the cardioembolic stroke subgroup, 60.0%
tim.hodson Tue, 02/04/2025 - 17:13 Feb. 3, 2025 Today, PeripheralArteryDisease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. Over time, this plaque can gradually narrow the arteries. What Is PAD?
Lorraine and Bill Dodero tim.hodson Fri, 02/14/2025 - 15:33 Feb. 10, 2025 A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio.
This transaction further extends Johnson & Johnson MedTech’s leadership in cardiovascular intervention. Johnson & Johnson expects the transaction to be accretive to operating margin, but considering the impact of financing costs, is expected to dilute adjusted earnings per share by approximately $0.10 in 2024 and approximately $0.17
tim.hodson Tue, 03/11/2025 - 11:02 March 11, 2025 The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, according to a new American Heart Association scientific statement published today in the Associations (..)
With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary arterydisease (CAD) and peripheralarterydisease (PAD). in 2024 and approximately $0.17
Lorraine and Bill Dodero tim.hodson Fri, 02/14/2025 - 15:33 Feb. 10, 2025 A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio.
Journal of the American Heart Association, Volume 14, Issue 5 , March 4, 2025. An increasing number of studies have shown the impact of social determinants of health (SDoHs) on different cardiovascular outcomes.
Stroke, Volume 56, Issue Suppl_1 , Page A136-A136, February 1, 2025. Acute brain infarction in multiple arterial territories could more strongly suggest a central embolic source. The trial screened all patients with cryptogenic stroke, regardless of infarct topography.
tim.hodson Mon, 01/13/2025 - 16:24 A new studyreports persistent disparities in outcomes for people with peripheralarterydisease (PAD) and its more severe form, chronic limb-threatening ischemia (CLTI) in the United States.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content